Raymond F Anton, M.D.

Accepting New Patients

Accepting New Patients

Provider Image

New Patients

843-792-9162 843-792-9162

Returning Patients

843-792-9162 843-792-9162

Title
  • Scientific Director of the Alcohol Research Center
  • Director, Clinical Neurobiology Laboratory
Degree M.D.
School Rutgers University
Residency
  • Yale School of Medicine
Board Certification
  • Psychiatry : Addiction Psychiatry
Specialties
  • Psychiatry - Drug & Alcohol Programs
Accepts New Patients Yes

New Patients

843-792-9162 843-792-9162

To request an appointment call our representatives at 843-792-1414

Returning Patients

843-792-9162 843-792-9162

Locations

Institute of Psychiatry
67 President Street
Charleston, SC 29425
Map & Directions
 

Biography

<p>Raymond F. Anton, M.D., is an addiction psychiatrist and clinical neuroscientist. He is a distinguished university professor of psychiatry and behavioral science at the Medical University of South Carolina in Charleston, South Carolina, where he holds the Thurmond Wellness Endowed Chair. He the scientific director of an NIAAA-funded Alcohol Research Center, and the director of the Clinical Neurobiology Laboratory in the Department of Psychiatry.</p>

<p>Dr. Anton is a past-president of the Research Society on Alcoholism (RSA) and is currently on the board of directors (secretary) of the International Society for Biomedical Research on Alcoholism (ISBRA). He is an elected fellow to the American College of Neuropsychopharmacology and a distinguished life fellow of the American Psychiatric Association. He is also currently serving as chair of the ACTIVE workgroup, a consortium of academics, government agencies, and the pharmaceutical industry whose task it is to define the best methods for clinical trials for alcohol use disorders. He also holds a prestigious Career Development Award (K05) from NIAAA to assist in mentoring junior researchers and developing genetic and brain imaging technologies.</p>

<p>He is internationally known for his expertise in alcohol use disorder pharmacotherapy and the use of lab tests to identify various drinking patterns. He has published over 300 articles and book chapters and has active funding for incorporating neuroimaging and genetics into alcohol treatment trials. He also helped pioneer the clinical utility of the CDT blood test for the detection and monitoring of heavy alcohol use and has been a member of the International Federation of Clinical Chemistry workgroup on CDT measurement standardization. In June 2017, he was awarded the prestigious Henri Begleiter Award for Research Excellence by the Research Society on Alcoholism.</p>